To our knowledge, no studies have identified a positive association between HER2-overexpression and BPE in the unaffected breast, although at least one has reported an association between triple-negative breast cancer and increased BPE [31]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.